Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-12-07, Stock:ABBV, The news for the past five days is as follows:
2021-11-30: NEWS1: 10 Biotech Penny Stocks to Buy Now.NEWS2: AbbVie Submits Application for Risankizumab (SKYRIZI®) in Moderate to Severe Crohn's Disease to European Medicines Agency (EMA).
2021-12-01: NEWS1: AbbVie (ABBV) Files for Skyrizi to Treat Crohn's Disease in EU.NEWS2: 2 Ridiculously Cheap Dividend Stocks To Buy for 2022.
2021-12-02: NEWS1: ‘Brazen is probably an understatement’: Georgia inmate ran multi-million dollar scam from prison cell, posing as AbbVie employee.NEWS2: 3 Stocks That Could Make You Richer in December (and Beyond).
2021-12-03: NEWS1: AbbVie Provides Update on RINVOQ® (upadacitinib) for the Treatment of Rheumatoid Arthritis in the U.S..NEWS2: Warren Buffett’s Picks: 10 Stocks to Watch.NEWS3: 10 Dividend Stocks That Have Doubled Their Payouts.NEWS4: Pharma Stock Roundup: FDA Panel Vote for MRK COVID Pill, JNJ Omicron Jab Plan.
2021-12-06: NEWS1: Where Do Hedge Funds Stand On AbbVie Inc (ABBV)?.NEWS2: AbbVie (ABBV) Adds FDA-Issued New Warnings to Rinvoq's Label.NEWS3: Upadacitinib (RINVOQ®) Achieved Primary and Key Secondary Endpoints in First Phase 3 Induction Study in Patients with Crohn's Disease.

Answer: Rise